We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




HbA1c Test Underestimates Glucose Control in Hemodialysis Patients

By Labmedica staff writers
Posted on 25 Feb 2008
Print article
The standard hemoglobin A1c test (HbA1c) for estimating blood sugar control in people with diabetes is not accurate in those undergoing kidney hemodialysis.

HbA1c measures the percentage of hemoglobin (a protein in erythrocytes) that has reacted with glucose. This measure, also known as glycosylated hemoglobin, generally reflects blood sugar control over the previous 30-120 days.

A study, performed by researchers at Wake Forest University Baptist Medical Center (Winston-Salem, NC, USA), evaluated the HbA1c test 307 patients with diabetes, 258 with end-stage kidney disease on hemodialysis, and 49 who did not have kidney failure. The standard HbA1c test was compared with a newer test (glycated albumin [GA]), which measures the amount of blood sugar that has reacted with albumin, a protein in the plasma. The GA test reflects blood sugar control over the previous three to four weeks. Blood samples were also analyzed to determine recent blood sugar levels.

Compared to those without kidney failure, diabetic patients on hemodialysis had higher blood sugars and GA levels, despite lower HbA1c results. The relationship between GA and HbA1c differed between diabetic dialysis patients and those without kidney disease, indicating that the HbA1c did not accurately reflect blood sugar control in those on hemodialysis.

The major reason for the discrepancy appears to be that HbA1c depends on erythrocyte survival and these cells do not live as long in hemodialysis patients. Most dialysis patients have anemia requiring treatment with medications that stimulate erythrocyte production (erythropoietin).

Controlling blood sugar is important because high levels are risk factors for developing atherosclerosis and lead to higher rates of kidney disease, heart attack, stroke, nerve damage, and blindness. People with diabetes who undergo hemodialysis are especially at high risk. About one out of four diabetic dialysis patients (23%) in the United States will die from cardiovascular and infection complications during their first year on dialysis, and only 31% survive five years.


Related Links:
Wake Forest University Baptist Medical Center
Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.